Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells

Nitric Oxide - Biology and Chemistry

Volumn 15, Issue 3, 2006, Pages 259-263

  de Nigris, Filomena ^a   Williams Ignarro, Sharon ^b   Botti, Chiara ^a   Sica, Vincenzo ^a   Ignarro, Louis J ^b   Napoli, Claudio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

eNOS; Nitric oxide; Pomegranate juice

Indexed keywords

ANTIOXIDANT; BRADYKININ; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY; DOWN REGULATION; DRUG ACTIVITY; ENDOTHELIUM CELL; FRUIT JUICE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; NORTHERN BLOTTING; POMEGRANATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

BEVERAGES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; PUNICACEAE;

LYTHRACEAE;

EID: 33749065777     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.12.004     Document Type: Article

References (24)

1. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., Hofman A., Rosenblat M., Volkova N., Presser D., Attias J., Hayek T., and Fuhrman B. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res. 28 (2002) 49-62
2. Reaven P.D., Napoli C., Merat S., and Witztum J.L. Lipoprotein modification and atherosclerosis in aging. Exp. Gerontol. 34 (1999) 527-537
3. Napoli C., and Ignarro L.J. Nitric oxide and atherosclerosis. Nitric Oxide Biol. Chem. 5 (2001) 88-97
4. Liguori A., Abete P., Hayden J.M., Cacciatore F., Rengo F., Ambrosio G., Bonaduce D., Condorelli M., Reaven P.D., and Napoli C. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur. Heart J. 22 (2001) 2075-2084
5. Napoli C., and Lerman L.O. Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clinic Proc. 76 (2001) 619-631
6. de Nigris F., Lerman A., Ignarro L.J., Williams-Ignarro S., Sica V., Baker A.H., Lerman L.O., Geng Y.J., and Napoli C. Oxidation-sensitive mechanisms, vascular apoptosis, and atherosclerosis. Trends in Molecular Medicine 9 (2003) 351-359
7. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272 (1997) 20963-20966
8. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., and Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100 (1997) 2680-2690
9. Walsh K., Smith R.C., and Hyo-Soo K. Vascular cell apoptosis in remodeling, restenosis and plaque rupture. Circ. Res. 87 (2000) 184-188
10. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., and Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions In Children (FELIC) study. Lancet 354 (1999) 1234-1241
11. Schmidt A.M., Yan S.D., Wautier J.L., and Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84 (1999) 489-497
12. Napoli C., Lerman L.O., de Nigris F., Loscalzo J., and Ignarro L.J. Glycoxidized low-density lipoprotein downregulates endothelial nitric oxide synthase in human coronary cells. J. Am. Coll. Cardiol. 40 (2002) 1515-1522
13. de Nigris F., Williams-Ignarro S., Lerman L.O., Crimi E., Botti C., Mansueto G., D'Armiento F.P., De Rosa G., Sica V., Ignarro L.J., and Napoli C. Beneficial effects of pomegranate juice on oxidation-sensitive genes and enos activity at sites of perturbed shear-stress. Proc. Natl. Acad. Sci. USA 102 (2005) 4896-4901
14. Liao J.K., Shin W.S., Lee W.Y., and Clark S.L. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270 (1995) 319-330
15. Chen C.Y.A., and Shu B. Au-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20 (1995) 465-470
16. Aviram M., Dornfeld L., Kaplan M., Coleman R., Gaitini D., Nitecki S., Hofman A., Rosenblat M., Volkova N., Presser D., Attias J., Hayek T., and Fuhrman B. Pomegranate juice flavonoids inhibit low-density lipoprotein and cardiovascular diseases: studies in atherosclerotic mice and humans. Drugs Exp. Clin. Res. 28 (2002) 49-62
17. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., and Aviram M. Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin, or catechin, is associated with reduced susceptibility of LDL to oxidation and to aggregation. Arterioscler Thromb Vasc. Biol. 17 (1997) 2744-2752
18. Aviram M., and Fuhrman B. Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 137 suppl. (1998) S45-S50
19. Aviram M., and Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158 (2001) 195-198
20. Aviram M., Rosenblat M., Gaitini D., Nitecki S., Hoffman A., Dornfeld L., Volkova N., Presser D., Attias J., Liker H., and Hayek T. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. 23 (2004) 423-433
21. Lou F.Q., Zhang M.F., Zhang X.G., Liu J.M., and Yuan W.L. A study on tea-pigment in prevention of atherosclerosis. Chin. Med. J. (Engl.) 102 (1989) 579-583
22. Duffy S.J., Keaney Jr. J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B., and Vita J.A. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104 (2001) 151-156
23. Chou E.J., Keevil J.G., Aeschlimann S., Wiebe D.A., Folts J.D., and Stein J.H. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am. J. Cardiol. 88 (2001) 553-555
24. Ignarro L.J., and Napoli C. Novel features on nitric oxide, endothelial nitric oxide synthase and atherosclerosis. Curr. Atheroscler. Rep. 6 (2004) 278-287